J Thomas Roland
Overview
Explore the profile of J Thomas Roland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
253
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marinelli J, Herberg H, Moore L, Yancey K, Kay-Rivest E, Casale G, et al.
Otolaryngol Head Neck Surg
. 2025 Feb;
PMID: 39927827
Objective: Limited evidence guides the optimal timing of treatment after the detection of tumor growth during the observation of sporadic vestibular schwannoma (VS). The current work aimed to inform the...
2.
Sennaroglu L, Lenarz T, Roland J, Lee D, Colletti L, Behr R, et al.
Cochlear Implants Int
. 2024 Nov;
25(4):316-333.
PMID: 39607757
Objectives: This study aims to synthesize current knowledge and outcomes related to pediatric auditory brainstem implantation (ABI) in children with severe inner ear malformations (IEMs). It highlights the clinical management...
3.
Dastagirzada Y, Eremiev A, Wisoff J, Kay-Rivest E, Shapiro W, Unterberger A, et al.
J Neurosurg Pediatr
. 2024 Mar;
33(5):496-504.
PMID: 38427998
Objective: Pediatric data regarding treatment via an auditory brainstem implant (ABI) remains sparse. The authors aimed to describe their experience at their institution and to delineate associated demographic data, audiometric...
4.
Berger A, Alzate J, Bernstein K, Mullen R, McMenomey S, Jethanemest D, et al.
Neurosurgery
. 2022 Aug;
91(4):648-657.
PMID: 35973088
Background: For patients with vestibular schwannoma (VS), stereotactic radiosurgery (SRS) has proven effective in controlling tumor growth while hearing preservation remains a key goal. Objective: To evaluate hearing outcomes in...
5.
Dastagirzada Y, Klauberg O, Sheerin K, Lieberman S, Lebowitz R, McMenomey S, et al.
J Neurol Surg B Skull Base
. 2022 Jul;
83(Suppl 2):e169-e172.
PMID: 35832935
Soon after the World Health Organization declared the severe acute respiratory syndrome coronavirus 2 a global health emergency on January 30, 2020, New York City was plagued by the virus...
6.
Marinelli J, Schnurman Z, Killeen D, Nassiri A, Hunter J, Lees K, et al.
Neuro Oncol
. 2021 Dec;
24(8):1298-1306.
PMID: 34964894
Background: The current study aims to characterize the natural history of sporadic vestibular schwannoma volumetric tumor growth, including long-term growth patterns following initial detection of growth. Methods: Volumetric tumor measurements...
7.
Gurewitz J, Schnurman Z, Nakamura A, Navarro R, Patel D, McMenomey S, et al.
J Neurosurg
. 2021 Aug;
136(3):768-775.
PMID: 34416729
Objective: In this study, the authors aimed to clarify the relationship between hearing loss and tumor volumetric growth rates in patients with untreated vestibular schwannoma (VS). Methods: Records of 128...
8.
Karajannis M, Mauguen A, Maloku E, Xu Q, Dunbar E, Plotkin S, et al.
Mol Cancer Ther
. 2021 Jul;
20(9):1584-1591.
PMID: 34224367
Inhibition of mTORC1 signaling has been shown to diminish growth of meningiomas and schwannomas in preclinical studies, and clinical data suggest that everolimus, an orally administered mTORC1 inhibitor, may slow...
9.
Nisenbaum E, Roland J, Waltzman S, Friedmann D
Otol Neurotol
. 2020 Jul;
41(7):e823-e828.
PMID: 32658104
Objective: To determine factors associated with infection, management, and resultant outcomes following pediatric cochlear implantation. Study Design: Retrospective cohort study with nested case series. Setting: Tertiary academic medical center. Patients:...
10.
Schnurman Z, Nakamura A, McQuinn M, Golfinos J, Roland J, Kondziolka D
J Neurosurg
. 2019 Aug;
133(3):742-748.
PMID: 31374553
Objective: There remains a large discrepancy among surgeons in expectations of vestibular schwannoma (VS) growth. The anticipated growth rate of a VS and its potential clinical impact are important factors...